Literature DB >> 7254713

Endogenous opiates and nociception: a possible functional role in both pain inhibition and detection as revealed by intrathecal naloxone.

A H Dickenson, D Le Bars, J M Besson.   

Abstract

Naloxone, the opiate antagonist, was injected into the intrathecal space of rats in doses of 15, 30 and 60 micrograms to gauge its effect on the nociceptive threshold as measured by the vocalization test. Whereas 60 micrograms of naloxone produced hyperalgesia, injections of 15 micrograms lead to hypoalgesia. These opposite effects of naloxone depending on the dose used do not support the idea that endogenous opiates have unequivocal effects on pain transmission, and an alternative hypothesis of their role is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7254713     DOI: 10.1016/0304-3940(81)90241-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord.

Authors:  D A Skyba; R Radhakrishnan; J J Rohlwing; A Wright; K A Sluka
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

Review 2.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

3.  Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults.

Authors:  Christopher R France; Mustafa al'Absi; Christopher Ring; Janis L France; Angie Harju; Lorentz E Wittmers
Journal:  Biol Psychol       Date:  2006-12-27       Impact factor: 3.251

Review 4.  Spinal opioid systems in inflammation.

Authors:  L Stanfa; A Dickenson
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

5.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.